SG10201913509YA - Therapeutic sall4 peptide - Google Patents

Therapeutic sall4 peptide

Info

Publication number
SG10201913509YA
SG10201913509YA SG10201913509YA SG10201913509YA SG10201913509YA SG 10201913509Y A SG10201913509Y A SG 10201913509YA SG 10201913509Y A SG10201913509Y A SG 10201913509YA SG 10201913509Y A SG10201913509Y A SG 10201913509YA SG 10201913509Y A SG10201913509Y A SG 10201913509YA
Authority
SG
Singapore
Prior art keywords
therapeutic
sall4 peptide
sall4
peptide
therapeutic sall4
Prior art date
Application number
SG10201913509YA
Inventor
Bee Liu
Daniel Tenen
Li Chai
Cheng San Chia
Anders Poulsen
Original Assignee
Nat Univ Singapore
Brigham & Womens Hospital Inc
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Univ Singapore, Brigham & Womens Hospital Inc, Agency Science Tech & Res filed Critical Nat Univ Singapore
Publication of SG10201913509YA publication Critical patent/SG10201913509YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG10201913509YA 2016-04-28 2017-04-28 Therapeutic sall4 peptide SG10201913509YA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662329010P 2016-04-28 2016-04-28

Publications (1)

Publication Number Publication Date
SG10201913509YA true SG10201913509YA (en) 2020-02-27

Family

ID=60161190

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201913509YA SG10201913509YA (en) 2016-04-28 2017-04-28 Therapeutic sall4 peptide
SG11201809315YA SG11201809315YA (en) 2016-04-28 2017-04-28 Therapeutic sall4 peptide

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201809315YA SG11201809315YA (en) 2016-04-28 2017-04-28 Therapeutic sall4 peptide

Country Status (4)

Country Link
US (1) US10793601B2 (en)
CN (1) CN109862903B (en)
SG (2) SG10201913509YA (en)
WO (1) WO2017190032A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020536853A (en) * 2017-10-04 2020-12-17 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド Small molecule inhibition of the transcription factor SALL4 and its use
CN109666064B (en) * 2018-12-29 2022-04-05 上海锐赛生物技术有限公司 SALL4-RBBp4 compound blocking polypeptide and derivative antitumor polypeptide and application thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3719667A (en) 1970-08-24 1973-03-06 Lilly Co Eli Epimerization of 6-acylamido and 6-imido penicillin sulfoxide esters
US3840556A (en) 1971-05-28 1974-10-08 Lilly Co Eli Penicillin conversion by halogen electrophiles and anti-bacterials derived thereby
US6686333B1 (en) * 1996-10-04 2004-02-03 The United States Of America As Represented By The Department Of Health And Human Resources Inhibition of HIV replication using soluble Tat peptide analogs
US6699466B1 (en) * 1999-08-05 2004-03-02 Research Corporation Technologies, Inc. IL-16 antagonist peptides and DNA encoding the peptides
US20050136040A1 (en) * 2001-10-11 2005-06-23 Imperial College Innovations Limited Control of gene expression using a complex of an oligonucleotide and a regulatory peptide
AU2006320654A1 (en) * 2005-11-29 2007-06-07 Yupo Ma Targeting of SALL4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)
CN101528926A (en) * 2006-08-18 2009-09-09 肿瘤疗法科学股份有限公司 Treating or preventing cancers over-expressing REG4 or KIAA0101
EP2609193A4 (en) * 2010-08-23 2014-02-26 Univ New York State Res Found Method for expansion of stem cells and the use of such cells
SG10201602149XA (en) * 2011-09-20 2016-04-28 Brigham & Womens Hospital SALL4 And Uses Thereof
EP2838541A1 (en) * 2012-04-20 2015-02-25 Agency For Science, Technology And Research Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies
SG11201605259QA (en) * 2013-12-30 2016-07-28 Agency Science Tech & Res Methods for measuring biomarkers in gastrointestinal cancer
EP3160989A2 (en) * 2014-06-26 2017-05-03 Xigen Inflammation Ltd. New use for jnk inhibitor molecules for treatment of various diseases

Also Published As

Publication number Publication date
US20190218253A1 (en) 2019-07-18
CN109862903A (en) 2019-06-07
WO2017190032A2 (en) 2017-11-02
SG11201809315YA (en) 2018-11-29
CN109862903B (en) 2023-04-14
US10793601B2 (en) 2020-10-06
WO2017190032A3 (en) 2017-12-21

Similar Documents

Publication Publication Date Title
IL265463A (en) Therapeutic mots-c related peptides
GB201520559D0 (en) Peptides
GB201607534D0 (en) Peptides
ZA201902689B (en) Therapeutic protein
GB201520546D0 (en) Peptides
GB201520536D0 (en) Peptides
GB201604468D0 (en) Peptides
GB201520545D0 (en) Peptides
GB201520563D0 (en) Peptides
GB201520567D0 (en) Peptides
GB201520544D0 (en) Peptides
GB201520543D0 (en) Peptides
GB201520541D0 (en) Peptides
GB201520539D0 (en) Peptides
GB201520562D0 (en) Peptides
GB201520550D0 (en) Peptides
GB201520566D0 (en) Peptides
SG10201913509YA (en) Therapeutic sall4 peptide
GB201612150D0 (en) Modified peptide
GB201607535D0 (en) Peptides
GB201520564D0 (en) Peptides
GB201520548D0 (en) Peptides
GB201520557D0 (en) Peptides
GB201520542D0 (en) Peptides
HK1251873A1 (en) Therapeutic peptides